Speakers index
๐
Article
๐
2011
๐
John Wiley and Sons
๐
French
โ 411 KB
The concept of angiogenesis as a target for the treatment of cancer has been considered for many years but only with the biological and molecular identification of one of the key mediators of angiogenesis, vascular endothelial growth factor (VEGF), have clinical trials in this field been truly feasi